Does Bio-Techne Corporation (TECH) Pay a Dividend? (2026)

Yes. Bio-Techne Corporation pays a dividend yielding roughly 0.44% as of July 2026, paid quarterly, four times a year. The most recent payment on record was $0.0800 per share with an ex-dividend date of May 18, 2026. That works out to a forward annual rate of about $0.32 per share. Yields move with the share price, so verify the current figure with your broker or TECH's investor relations page before relying on it.

About 0.44% as of July 2026. On a $10,000 position that is roughly $44 of dividend income a year before tax. For context, the S&P 500 yields around 1.2%, so TECH yields meaningfully less than the broad market. A higher yield is not automatically better: it can reflect a falling share price as easily as a generous payout, so it is worth checking why the number is what it is.

Bio-Techne Corporation pays quarterly, four times a year. The most recent payment on record had an ex-dividend date of May 18, 2026. To receive a given payment you have to own the shares before the ex-dividend date, not on the pay date. Confirm upcoming dates on TECH's investor relations page, because boards can change both the amount and the timing.

The ex-dividend date recorded in our July 2026 data pull is May 18, 2026. The ex-dividend date is the cutoff: buy on or after it and the seller keeps that payment, not you. Buying just before the ex-date to capture the dividend does not create free money, because the share price typically drops by roughly the dividend amount when the stock goes ex. Check TECH's investor relations page for the next confirmed date.

$0.0800 per share in the most recent payment (ex-date May 18, 2026), which annualizes to about $0.32 per share. The equivalent payment a year earlier was $0.0800. That is a change of 0.0% year over year.

Not in the last year. The latest payment of $0.0800 per share is unchanged from the $0.0800 paid a year earlier. A flat dividend is not necessarily a warning sign, but it does mean the income is losing ground to inflation.

Bio-Techne Corporation paid out about 46% of its earnings as dividends, so the payout is comfortably covered. That is the range most established dividend payers sit in: enough profit is retained to keep funding the business, with room to raise the dividend if earnings grow. Nobody can guarantee a dividend: boards cut them, and a high yield is sometimes the market pricing in exactly that. Walnut is not an investment adviser and this is not a recommendation.

At a yield of about 0.44%, roughly $44 a year before tax, spread across 4 payments. That is a snapshot, not a promise: the amount changes when the company changes its payout, and your yield on cost is fixed at the price you paid, not at today's price.

Dividends from US common stock are usually qualified, meaning they are taxed at the lower long-term capital-gains rates, provided you held the shares for more than 60 days in the 121-day window around the ex-dividend date. Distributions from REITs, BDCs, and some pass-through structures are generally taxed as ordinary income instead. In an IRA or Roth the question does not arise. See our guide to how dividends are taxed. This is not tax advice.

Most brokers offer automatic reinvestment (a DRIP) that puts each TECH payment straight back into more shares, often fractional ones. Reinvesting compounds the position and is the standard choice when you do not need the cash yet. Taking the cash makes sense when you are spending the income or want to direct it elsewhere. Either way the dividend is taxable in a taxable account in the year it is paid, even if you never see the money.

Bio-Techne has historically paid a small dividend, though its yield has been modest relative to the share price, so income has not been the main reason most investors held it. With a cash acquisition pending, capital-return plans can change as the deal progresses. Always check the latest declared dividend and the current status of the transaction before assuming any payout.